Literature DB >> 2302663

The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival.

A T Stotter1, R P A'Hern, C Fisher, A F Mott, M E Fallowfield, G Westbury.   

Abstract

One hundred seventy-five consecutive patients with soft tissue sarcoma of the limb and limb girdle were studied using univariate and multivariate analysis. The most important factor determining risk of local recurrence was the quality of treatment of the primary tumor, with wide or radical surgery plus radical radiotherapy obtaining the best local control. Tumor size, site, and histologic grade were not predictive of local recurrence. The important tumor variables predicting survival were tumor size at first presentation and histologic grade. Tumors with greater than 10 cm greatest diameter and high-grade tumors carried a poor prognosis. Local recurrence was significantly associated with reduced survival, but only when (correctly) considered as a time-dependent variable in multivariate analysis. Irradiation was also significantly associated with poor survival. Review of the literature indicates that local recurrence is believed to have little influence on survival. Since the relevant randomized controlled trials have been small, the evidence is inconclusive.

Entities:  

Mesh:

Year:  1990        PMID: 2302663     DOI: 10.1002/1097-0142(19900301)65:5<1119::aid-cncr2820650515>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  21 in total

1.  Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity.

Authors:  A Stotter
Journal:  Ann Surg       Date:  1992-11       Impact factor: 12.969

2.  Patient with synchronous low grade leiomyosarcoma of the thigh, primary pancreatic neuroendocrine tumor, and lung metastases: Why biopsy of metastases should be the standard.

Authors:  Jesus Fabregas; Tony N Talebi; Caio Rocha Lima; George N Sfakianakis; Philip Robinson; Alberto J Montero
Journal:  J Gastrointest Oncol       Date:  2011-06

3.  Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience.

Authors:  A M Eggermont; H Schraffordt Koops; J M Klausner; B B Kroon; P M Schlag; D Liénard; A N van Geel; H J Hoekstra; I Meller; O E Nieweg; C Kettelhack; G Ben-Ari; J C Pector; F J Lejeune
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

4.  Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities.

Authors:  Chigusa Sawamura; Dempsey S Springfield; Karen J Marcus; Antonio R Perez-Atayde; Mark C Gebhardt
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  Soft tissue sarcomas of the extremities and trunk in the adult. Report of 124 cases.

Authors:  C Zornig; H J Weh; A Krüll; R Schwarz; R E Hilgert; S Schröder
Journal:  Langenbecks Arch Chir       Date:  1992

Review 6.  Soft tissue tumours.

Authors:  A J Hayes; J M Thomas
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

7.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

8.  [Local recurrence of soft tissue sarcoma of the extremities and trunk].

Authors:  M Peiper; D Zurakowski; C Zornig
Journal:  Langenbecks Arch Chir       Date:  1995

9.  High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.

Authors:  Fritz C Eilber; Gerald Rosen; Scott D Nelson; Michael Selch; Frederick Dorey; Jeffery Eckardt; Frederick R Eilber
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

Review 10.  Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.

Authors:  Cornelis Verhoef; Johannes H W de Wilt; Dirk J Grünhagen; Albertus N van Geel; Timo L M ten Hagen; Alexander M M Eggermont
Journal:  Curr Treat Options Oncol       Date:  2007-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.